VRTS Price Prediction Next Week
Analysis and Insights
Technical Analysis:
Virtus Investment Partners Inc (VRTS) has entered oversold territory with an RSI of 29.2, indicating potential buying opportunities. The stock recently fell to $167.13, suggesting a possible rebound.
Valuation Analysis:
VRTS offers a dividend yield of 5.22%, attractive for income-focused investors. The company has consistently increased dividends, a positive sign for investors.
Fibonacci Levels:
Key levels for VRTS include resistance at $179.72 and support at $169.18. Breaking above resistance could signal an uptrend.
Recent Price Action:
The stock closed at $174.77 after hitting a low of $171.49, showing buying interest at lower levels.
Conclusion:
Given the oversold condition and attractive valuation, VRTS is expected to rebound. The stock price is predicted to rise to $179.72 next week, suggesting a buy recommendation.
Prediction: Buy VRTS with a target price of $179.72.
VRTS Similar Chart Price Prediction
The price of VRTS is predicted to go up -6.1%, based on the high correlation periods with GEL. The similarity of these two price pattern on the periods is 92.57%.
VRTS
GEL
Down: -6.1%Similarity: 92.57%
VRTS Revenue Forecast
VRTS EPS Forecast
VRTS FAQs
What is VRTS revenue forecast for next quarter？
What is VRTS eps forecast for next quarter？
VRTS Analyst's Forecast
Crispin Love
Piper Sandler
Buy
2025-01-21
Price Target
$274 → $258
Upside
+22.45%
Piper Sandler analyst Crispin Love lowered the firm's price target on Virtus Investment to $258 from $274 and keeps an Overweight rating on the shares. In conjunction with an industry note, the firm is adjusting our model to reflect the December AUM release and mark to market through January 14. For Q4, Piper is decreasing its adjusted EPS estimate to $7.26 from $7.37. It is also decreasing its 2025/2026 estimates by about 6% to $27.92/$29.87 from $29.79/$31.85 due to the MTM and lower average AUM from the $3.3B institutional outflow in December.
Benjamin Budish
Barclays
Sell
2025-01-17
Price Target
$239 → $221
Upside
+5.2%
Michael Cyprys
Morgan Stanley
Sell
2024-12-20
Price Target
$224 → $228
Upside
+3.17%
